Global Companion Animal Drugs Market Size, Share, Growth Analysis, By Medicine(Antibiotics, Anti-inflammatory Drugs), By Animal(Dogs, Cats) - Industry Forecast 2024-2031

Report ID: SQMIG35I2251 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

Global Companion Animal Drugs Market News

Dechra Pharmaceuticals is a global specialist in veterinary pharmaceuticals and related products which develops, produces, and sells high quality products for veterinarians across the world. The international business bought the animal health business of Idexx Laboratories in March 2023. This purchase can potentially put Dechra Pharmaceuticals at second place in the global animal health market.

Boehringer Ingelheim is one of the world's largest pharmaceutical companies, according to a report in 2018. This company offers solutions to human pharmaceuticals, animal health, and biopharmaceuticals companies. They bought Aureus Pharma in February 2023. Aureus Pharma is a private company that identifies, develops, and delivers nutraceutical products. This purchase will expand Boehringer Ingelheim’s product offerings that serve the companion animal drug market.

Zoetis is the largest global animal health company. It is also the world's largest producer of medicine and vaccinations for pets and livestock. This global brand purchased Abaxis in January 2023. Abaxis is a globally leading supplier of vitro diagnostic products and services that cater to the companion animals drugs market. As a result of this, Zoetis can retain its place in the market.

Global Companion Animal Drugs Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Companion Animal Drugs Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global market for companion animal drugs is defined by a very competitive environment. Key market players are constantly engaged in fierce rivalry. This intense competition among the participants is driven by the rising demand in the market. Some of the renowned names in the industry include Elanco, Boehringer Ingelheim, Zoetis, and Bayer Animal Health. These firms lead the market. Their acquisition of the large market shares is owed to the several advantages they possess. One of them is their wide range of pet healthcare product and service offerings. These include parasiticides, vaccines, and anti-infectives, among other therapeutic medicines. 'Zoetis Inc. (USA)', 'Elanco Animal Health Inc. (USA)', 'Merck & Co., Inc. (USA)', 'Boehringer Ingelheim (Germany)', 'Bayer AG (Germany)', 'Virbac (France)', 'Ceva Santé Animale (France)', 'Vetoquinol S.A. (France)', 'Nexvet (USA)', 'IDEXX Laboratories, Inc. (USA)', 'Biogenesis Bago (Argentina)', 'Nutramax Laboratories, Inc. (USA)', 'Heska Corporation (USA)', 'Merial (Sanofi) (France)', 'Animalcare Group PLC (United Kingdom)', 'Kindred Biosciences (USA)', 'Norbrook Laboratories (Ireland)', 'Kyoritsu Seiyaku Corporation (Japan)', 'TVM Laboratories (France)', 'Dechra Pharmaceuticals PLC (United Kingdom)'

The market for companion animal drugs is on the rise due to improvements in veterinary medicine. These advancements include the development of better working diagnostics, treatments, and pharmaceuticals. The market is seeing an expansion in the diversity of treatment options due to these improvements. Other changes include better disease management and enhanced efficacy. This has boosted the desire for advanced companion animal medication.

Digital Health Solutions: Veterinary medicine is seeing some changes. The adoption of data analytic and other digital technology has transformed the field. Wearable devices, telehealth services, and mobile apps have been integrated into the scene. This has helped pet owners in remotely monitoring their pet’s health indicators. These devices also help communication with consulting vets. The new technology can also help manage medicinal prescriptions and follow them to a tee.

North America is at the top of the market for companion animal drugs. The US has made large contributions to this region’s large market share. The region’s wide pet adoption rate and expensive healthcare spending have cemented its position in the market. Additionally, major pharmaceutical companies that produce and distribute pet medications reside in North America.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Companion Animal Drugs Market Size, Share, Growth Analysis, By Medicine(Antibiotics, Anti-inflammatory Drugs), By Animal(Dogs, Cats) - Industry Forecast 2024-2031

Global Companion Animal Drugs Market News

Global Companion Animal Drugs Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Companion Animal Drugs Market?

Who are the key vendors in the Global Companion Animal Drugs Market?

What is the key driver of Global Companion Animal Drugs Market?

What is the key market trend for Global Companion Animal Drugs Market?

Which region accounted for the largest share in Global Companion Animal Drugs Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300